Profile | GDS4284 / 1554285_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 222.186 | 51 |
GSM687648 | Patient 402 control | 272.641 | 54 |
GSM687653 | Patient 403 control | 72.6594 | 30 |
GSM687658 | Patient 404 control | 171.263 | 45 |
GSM687663 | Patient 411 control | 313.543 | 56 |
GSM687668 | Patient 422 control | 198.118 | 49 |
GSM687673 | Patient 424 control | 254.719 | 52 |
GSM687678 | Patient 425 control | 178.527 | 45 |
GSM687683 | Patient 427 control | 208.622 | 47 |
GSM687688 | Patient 428 control | 178.163 | 46 |
GSM687695 | Patient 441 control | 669.915 | 68 |
GSM687699 | Patient 443 control | 311.617 | 54 |
GSM687704 | Patient 444 control | 168.884 | 45 |
GSM687707 | Patient 448 control | 396.642 | 59 |
GSM687712 | Patient 449 control | 209.921 | 49 |
GSM687719 | Patient 450 control | 401.266 | 58 |
GSM687724 | Patient 451 control | 436.947 | 61 |
GSM687728 | Patient 452 control | 481.115 | 63 |
GSM687646 | Patient 401 treated 24h | 97.0026 | 34 |
GSM687649 | Patient 402 treated 24h | 180.414 | 48 |
GSM687665 | Patient 411 treated 24h | 223.054 | 48 |
GSM687651 | Patient 402 treated 4 weeks | 216.977 | 49 |
GSM687667 | Patient 411 treated 4 weeks | 212.861 | 49 |
GSM687670 | Patient 422 treated 24h | 328.518 | 56 |
GSM687671 | Patient 422 treated 4 weeks | 201.143 | 49 |
GSM687654 | Patient 403 treated 24h | 99.5902 | 37 |
GSM687675 | Patient 424 treated 24h | 308.233 | 55 |
GSM687685 | Patient 427 treated 24h | 268.906 | 53 |
GSM687656 | Patient 403 treated 4 weeks | 149.173 | 45 |
GSM687677 | Patient 424 treated 4 weeks | 121.071 | 38 |
GSM687687 | Patient 427 treated 4 weeks | 242.214 | 53 |
GSM687692 | Patient 428 treated 4h | 237.953 | 51 |
GSM687716 | Patient 449 treated 4h | 150.61 | 43 |
GSM687722 | Patient 450 treated 4h | 449.858 | 61 |
GSM687680 | Patient 425 treated 24h | 287.567 | 55 |
GSM687690 | Patient 428 treated 24h | 309.739 | 57 |
GSM687700 | Patient 443 treated 24h | 522.432 | 62 |
GSM687705 | Patient 444 treated 24h | 202.053 | 50 |
GSM687714 | Patient 449 treated 24h | 287.645 | 56 |
GSM687721 | Patient 450 treated 24h | 304.685 | 53 |
GSM687682 | Patient 425 treated 4 weeks | 76.2017 | 30 |
GSM687694 | Patient 428 treated 4 weeks | 255.35 | 54 |
GSM687702 | Patient 443 treated 4 weeks | 340.316 | 56 |
GSM687718 | Patient 449 treated 4 weeks | 308.253 | 56 |
GSM687723 | Patient 450 treated 4 weeks | 290.573 | 54 |
GSM687661 | Patient 404 treated 4h | 209.168 | 48 |
GSM687710 | Patient 448 treated 4h | 297.527 | 56 |
GSM687726 | Patient 451 treated 4h | 239.222 | 49 |
GSM687730 | Patient 452 treated 4h | 561.354 | 59 |
GSM687660 | Patient 404 treated 24h | 220.299 | 46 |
GSM687697 | Patient 441 treated 24h | 760.325 | 70 |
GSM687709 | Patient 448 treated 24h | 361.472 | 58 |
GSM687725 | Patient 451 treated 24h | 389.821 | 58 |
GSM687729 | Patient 452 treated 24h | 496.422 | 63 |
GSM687727 | Patient 451 treated 4 weeks | 122.311 | 34 |
GSM687731 | Patient 452 treated 4 weeks | 521.113 | 64 |